Rp-8-CPT-cAmPS

Catalog No. :
ACFFDZ194
CAS No. :
129735-01-9
Molecular Formula :
C16H15ClN5O5PS2
Molecular Weight :
487.89

IUPAC Name:(2R,4aR,6R,7R,7aS)-6-(6-amino-8-((4-chlorophenyl)thio)-9H-purin-9-yl)-7-hydroxy-2-mercaptotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide

Rp-8-CPT-cAmPS structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRp-8-CPT-cAmPS
IUPAC Name(2R,4aR,6R,7R,7aS)-6-(6-amino-8-((4-chlorophenyl)thio)-9H-purin-9-yl)-7-hydroxy-2-mercaptotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide
Molecular FormulaC16H15ClN5O5PS2
Molecular Weight487.89
SMILESNC1=C2N=C(SC3=CC=C(Cl)C=C3)N([C@@H]3O[C@@H]4CO[P@@](=O)(S)O[C@H]4[C@H]3O)C2=NC=N1
InChI KeyIVNQJYQKSYRLTE-FUWBYEKLSA-N
Synonym8-(4-CHLOROPHENYLTHIO)ADENOSINE-*3',5-CYCLIC MONOPH;RP-8-CPT-CAMPS;RP-8-CPT-CAMPS SODIUM SALT;8-(4-chlorophenylthio)adenosine-3’,5’-cyclicmonophosphorothioate,spisomer(sp-8-cpt-camps),sodi;8-(4-CHLOROPHENYLTHIO)ADENOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, RP-ISOMER;8-(4-CHLOROPHENYLTHIO)ADENOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, RP-ISOMER SODIUM SALT;Adenosine, 8-[(4-chlorophenyl)thio]-, cyclic 3',5'-[hydrogen [P(R)]-phosphorothioate]
CAS No.129735-01-9

Synthetic Route by SureRoute

1. ACFFDZ194 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFFDZ194 route product structure diagram
    ACFFDZ194129735-01-9
Inquiry

2. ACFFDZ194 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFFDZ194 route product structure diagram
    ACFFDZ194129735-01-9
Inquiry

Comments (0)